University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Treatment > ARV Charts and Tables > Antiretrovirals
FDA-Approved and Investigational Antiretrovirals
Reverse Transcriptase Inhibitors (RTIs)
transparent image
Nucleoside/Nucleotide Analogues (NRTIs)
transparent image
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Protease Inhibitors (PIs)
Fixed-Dose Combination Antiretrovirals
Fusion Inhibitors
Chemokine Coreceptor Antagonists
Integrase Inhibitors
Maturation Inhibitors
Reverse Transcriptase Inhibitors (RTIs)
Nucleoside/Nucleotide Analogues (NRTIs)
FDA Approved
Investigational
generic name
abbreviation
brand name (code)
pharmaceutical co.
abacavir
ABC
Ziagen
GlaxoSmithKline
---
RCV
Racivir
Pharmasset
didanosine
ddI
Videx, Videx EC
Bristol-Myers Squibb
elvucitabine
---
(ACH-126,443),(Beta-L-Fd4C)
Achillion Pharmaceuticals
emtricitabine
FTC
Emtriva
Gilead
apricitabine
---
(AVX754)
Avexa
lamivudine
3TC
Epivir
GlaxoSmithKline
stavudine
d4T
Zerit
Bristol-Myers Squibb
tenofovir
TDF
Viread
Gilead
zalcitabine
* ddC
Hivid
Roche
zidovudine
AZT or ZDV
Retrovir
GlaxoSmithKline, Ranbaxy Laboratories, Aurobindo Pharma, Roxane Laboratories
* Zalcitabine discontinued
Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)
FDA Approved
Investigational
generic name
abbreviation
brand name (code)
pharmaceutical co.
delavirdine
DLV
Rescriptor
Pfizer
rilpivirine
---
(TMC 278)
Tibotec
efavirenz
EFV
Sustiva, Stocrin
Bristol-Myers Squibb/
Merck Sharp & Dohme
etravirine

Intelence (TMC125)
Tibotec
nevirapine
NVP
Viramune
Boehringer Ingelheim
Protease Inhibitors (PIs)
FDA Approved
Investigational
generic name
abbreviation
brand name (code)
pharmaceutical co.
amprenavir*
APV
Agenerase
GlaxoSmithKline
atazanavir
ATV
Reyataz
Bristol-Myers Squibb
darunavir
DRV
Prezista (TMC 114)
Tibotec
fosamprenavir
FPV
Lexiva, Telzir
Vertex / GlaxoSmithKline
indinavir
IDV
Crixivan
Merck
lopinavir (w/ritonavir)
LPV
Kaletra, Aluvia
Abbott
nelfinavir
NFV
Viracept
Pfizer
ritonavir
RTV
Norvir
Abbott
saquinavir
SQV
Fortovase #, Invirase
Roche
tipranavir
TPV
Aptivus
Boehringer Ingelheim
* Amprenavir discontinued in U.S.
# Fortovase formulation discontinued
Fixed-Dose Combination Antiretrovirals
FDA Approved
Investigational
generic name
abbreviation
brand name (code)
pharmaceutical co.
zidovudine/lamivudine
fixed-dose

AZT/3TC fixed-dose
Combivir
GlaxoSmithKline
zidovudine/lamivudine/
abacavir fixed-dose

AZT/3TC/ABC fixed-dose
Trizivir
GlaxoSmithKline
abacavir/lamivudine
fixed-dose

ABC/3TC fixed-dose
Epzicom, Kivexa
GlaxoSmithKline
emtricitabine/tenofovir
fixed-dose

FTC/TDF fixed-dose
Truvada
Gilead
efavirenz/emtricitabine/tenofovir
fixed-dose

EFV/FTC/TDF fixed-dose
Atripla
Bristol-Myers Squibb / Gilead
Fusion Inhibitors
FDA Approved
Investigational
generic name
abbreviation
brand name (code)
pharmaceutical co.
enfuvirtide
ENF
Fuzeon, (T-20)
Trimeris / Roche
---
---
(TNX-355)
Tanox Inc
Chemokine Coreceptor Antagonists
FDA Approved
Investigational
generic name
abbreviation
brand name (code)
pharmaceutical co.
maraviroc
MVC
Selzentry (UK-427,857);
Celsentri (outside U.S.)

Pfizer
vicriviroc
---
(SCH-417690 or SCH-D)
Schering
---
---
(PRO 140)
Progenics
--
--
(INCB9741)
Incyte Pharmaceuticals
Integrase Inhibitors
FDA Approved
Investigational
generic name
abbreviation
brand name (code)
pharmaceutical co.
raltegravir
RAL
Isentress (MK-0518)
Merck
elvitegravir
---
GS-9137
Gilead
---
---
(364735)
GlaxoSmithKline, Shionogi
Maturation Inhibitors
FDA Approved
Investigational
generic name
abbreviation
brand name (code)
pharmaceutical co.
bevirimat
---
(PA-457)
Panacos Pharmaceuticals